Jade Therapeutics is a biotechnology startup specializing in creating ophthalmic drug delivery systems that allow for sustained release. Founded in 2011, the company's primary aim is to develop treatments that are administered locally and offer extended therapeutic benefits, particularly for improving corneal healing after disease or injury, thereby enhancing visual function and overall quality of life. The company's product utilizes recombinant human growth hormone, a well-established biologic known for its healing properties, which it achieves by activating and recruiting crucial cells involved in tissue regeneration.
With its slogan of "Enhancing corneal healing with sustained-release therapeutics for improved visual function and quality of life," Jade Therapeutics is making strides in the Health Care industry by focusing on improving visual function and quality of life through its innovative treatment methods.
The startup received a $903.83K grant investment on 25 November 2014 from the National Science Foundation, signifying recognition and support for its groundbreaking approach to ophthalmic drug delivery and therapeutic solutions.
